24 - (Muscle Nerve 46: 400–406, 2012) DOXYCYCLINE AMELIORATES THE DYSTROPHIC PHENOTYPE OF SKELETAL AND CARDIAC MUSCLES IN mdx MICE

JULIANO ALVES PEREIRA,  ANA PAULA TIEMI TANIGUTI, CINTIA MATSUMURA, MARIA JULIA MARQUES,  HUMBERTO SANTO NETO - Brasil

ABSTRACT: Introduction: We examined whether doxycycline,an antibiotic member of the tetracycline family, improves the histopathology and muscle function in mdx mice, the experimental model of DMD. Methods: Doxycycline was administered for 36 days (starting on postnatal day 0) and for 9 months (starting at 8 months of age) in drinking water. Histopathological, biochemical (creatine kinase), and functional (forelimb muscle grip strength) parameters were evaluated in limb, diaphragm, and cardiac muscle. Results: Doxycycline significantly minimized the dystrophic phenotype of skeletal and cardiac muscles and improved forelimb muscle strength. The drug protected muscle fibers against myonecrosis and reduced inflammation. Furthermore, it slowed the progression of myocardial  fibrosis. Conclusions: This study provides evidence that doxycycline may be a potential therapeutic agent for DMD.

Views: 103

Reply to This

Replies to This Discussion

Thanks Amit for posting this. Again we have to wait and watch...........So, there are drugs but beyond our reach.

Reply to Discussion

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2020   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service